<DOC>
	<DOCNO>NCT02864654</DOCNO>
	<brief_summary>Adipose-derived regenerative cell ( ADRC ) extract lipoaspirate enzymatic digestion . 10 mL autologous ADRC suspension inject intramuscularly , close site muscle injury . All patient receive cell therapy . This single arm study control .</brief_summary>
	<brief_title>Effectiveness Safety Adipose-Derived Regenerative Cells Treatment Critical Lower Limb Ischemia</brief_title>
	<detailed_description>Fat tissue obtainment : Subjects undergo liposuction local anesthesia . In procedure , Ringer 's solution anesthetic lidocaine vasoconstrictor adrenaline infuse adipose compartment minimize blood loss contamination tissue peripheral blood cell . 15 minute later hollow blunt-tipped 3 mm cannula introduce subcutaneous space small ( 0.5 cm ) incision . The cannula attach syringe gentle suction move adipose compartment , mechanically disrupt fat tissue . Aspirate volume - approximately 150-200 cc . Procedure time - 30 minute . ADRC isolation : Harvested adipose tissue process accord patent pending technology base enzymatic digestion , wash concentration cell pellet 10.5 ml normal saline . Obtained ADRC divide 2 portion . First portion ( 0.5 mL ) use counting , viability sterility assessment . The second portion ( 10 ml ) place sterile syringe injection . Autologous ADRC administration 10 mL autologous ADRC suspension inject intramuscularly , close site muscle injury . 10 20 injection ( 0.5 1.0 mL ) perform infiltrate injured muscle .</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Arteriosclerosis</mesh_term>
	<mesh_term>Arteriosclerosis Obliterans</mesh_term>
	<mesh_term>Diabetic Angiopathies</mesh_term>
	<mesh_term>Thromboangiitis Obliterans</mesh_term>
	<criteria>Patients critical low limb ischemia , rest pain wich ca n't adequately manage opioid analgetics and/or foot ulcer necrosis , II4 , III5 и IV6 stag chronic arterial failure accord Rutherford 's classification Anklebrachial index less 0.4 and/or ТСрО2 le 30 mm Hg Patients low limb ' artery lesion reveal angiography uneffectiveness impossibility limb 's revascularisation patient 's refusal procedure Patient familiar Participant information sheet Patient sign informed consent form Noninclusion Criteria : Contraindications local anesthesia history allergy local anesthetic Systemic glucocorticoid and/or immunosuppressant therapy Any condition might limit compliance ( dementia , mental disorder , narcotic drug alcohol abuse etc . ) Participation clinical trial ( administration investigational drug ) 3 month prior inclusion Patients malignant tumor include postoperative period , patient receive chemotherapy and/or radiotherapy Clinically significant abnormality result laboratory test Patient receive anticoagulant least 12 hour prior liposuction Medical history heterotopic ossification Patients prescribed glycoprotein inhibitor treatment Patient 's refusal participation trial Chronic kidney disease IV V stage ( creatinine clearance &lt; 30 mL/min estimate CockcroftGault formula ) Confirmed syphilis , HIV , hepatitis B C infection Dropout Criteria : Indications amputation limb</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Critical low limb ischemia</keyword>
	<keyword>Atherosclerosis obliterans</keyword>
	<keyword>Diabetic angiopathy</keyword>
	<keyword>Thromboangiitis obliterans</keyword>
	<keyword>Ischemic ulcer</keyword>
	<keyword>Peripheral arterial disease</keyword>
	<keyword>Indirect revascularisation</keyword>
	<keyword>Intramuscular injection</keyword>
	<keyword>Ankle-brachial index</keyword>
	<keyword>Transcutaneous oxygen tension</keyword>
	<keyword>Stromal vascular fraction ( SVF )</keyword>
	<keyword>Adipose-derived regenerative cell ( ADRC )</keyword>
	<keyword>Adipose tissue</keyword>
	<keyword>Stem cell</keyword>
</DOC>